Unifying mechanism for anticancer agents involving electron transfer and oxidative stress: Clinical implications

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 510-516

  Kovacic, Peter ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; AMSACRINE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AROMATIC NITRO COMPOUND; ARSENIC DERIVATIVE; BLEOMYCIN; CAMPTOTHECIN; CISPLATIN; COLCHICINE; DACTINOMYCIN; DIETHYLDITHIOCARBAMIC ACID; EFLORNITHINE; ETOPOSIDE; FLAVONE; GOSSYPOL; HYDROXYLAMINE; HYDROXYUREA; IMINE; METAL COMPLEX; METAL DERIVATIVE; METALLOCENE DERIVATIVE; METHOTREXATE; MITOMYCIN C; NITROSO DERIVATIVE; PACLITAXEL; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER THERAPY; CATALYSIS; DRUG MECHANISM; ELECTROCHEMISTRY; ELECTRON TRANSPORT; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; DISEASE PROGRESSION; ELECTROCHEMISTRY; ELECTRON TRANSPORT; ELECTRONS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDES; QUINONES; REACTIVE OXYGEN SPECIES;

EID: 34447272264     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.08.046     Document Type: Article

References (41)

1. In: Chabner B.A., and Longo D.L. (Eds). Cancer chemotherapy and biotherapy: principles and practice (2006), Lippincott Williams & Wilkins, Philadelphia
2. Kovacic P., and Becvar L.E. Mode of action of anti-infective agents: focus on oxidative stress and electron transfer. Curr Pharmaceut Des 6 (2000) 143-167
3. Kovacic P., and Osuna J.A. Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr Pharmaceut Des 6 (2000) 277-309
4. Kovacic P., and Jacintho J.D. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 8 (2001) 773-796
5. Kovacic P., and Jacintho J.D. Reproductive toxins: pervasive theme of oxidative stress and electron transfer. Curr Med Chem 8 (2001) 863-892
6. Kovacic P., Sacman A., and Wu-Weis M. Nephrotoxins: widespread role of oxidative stress and electron transfer. Curr Med Chem 9 (2002) 823-847
7. Poli G., Cheeseman K.H., Dianzani M.U., and Slater T.F. Free radicals in the pathogenesis of liver injury (1989), Pergamon Press, NY
8. Kovacic P., and Somanathan R. Neurotoxicity: the broad framework of electron transfer, oxidative stress and protection by antioxidants. Curr Med Chem CNS Agents 5 (2005) 249-258
9. Kovacic P., and Thurn L.A. Cardiovascular toxicity from the perspective of oxidative stress, electron transfer, and prevention by antioxidants. Curr Vasc Pharmacol 3 (2005) 107-118
10. Kovacic P., Pozos R.S., Somanathan R., Shangari N., and O'Brien P.J. Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships. Curr Med Chem 12 (2005) 2601-2623
11. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford University Press, NY p. 1-859
12. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford University Press, NY p. 27-35, 430-84.
13. Traatjes D., Fenick D.J., Guadiano G., and Koch T.H. A redox pathway leading to the alkylation of nucleic acids by doxorubicin and related anthracyclines: application to the design of antitumor drugs for resistant cancer. Curr Pharmaceut Des 4 (1998) 203-218
14. Tomasz M., and Palom Y. The mitomycin bioreductive antitumor agents:cross-linking and alkylation of DNA as the molecular basis of their activity. Pharmacol Ther 76 (1997) 73-87
15. Cummings J., Spanswick V.J., Tomasz M., and Smyth J.F. Enzymology of mitomycin C metabolic activation in tumor tissue: implications for enzyme-directed bioreductive drug development. Biochem Pharmacol 56 (1998) 405-414
16. Pan S.S., and Gonzalez H. Mitomycin antibiotic reductive potential and related pharmacological activities. Mol Pharmacol 37 (1990) 966-970
17. Kovacic P., Ames J.R., and Ryan M.D. Electron transfer - oxy radical mechanism for anticancer agents. In: Dryhurst G., and Niki K. (Eds). Redox chemistry and interfacial behavior of biological molecules (1988), Plenum Press, New York 345-357
18. Gantchev T.G., and Hunting D.G. Inhibition of the topoisomerase II-DNA cleavable complex by the ortho-quinone derivative of the antitumor drug etoposide (VP-16). Biochem Biophys Res Commun 237 (1997) 24-27
19. Cai X.B., Jing X.B., Hu H., Chen S.Z., and Li Y.H. The role of reactive oxygen species in cisplatin-induced apoptosis of esophageal cancer cell line ec-109. Chin J Canc 25 (2006) 427-431
20. Masuda H., Tanaka T., and Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203 (1994) 1175-1180
21. Kovacic P., Popp W.G., Ames J.R., and Ryan M.D. Anti-cancer action of metal complexes: electron transfer and oxidative stress?. Anti-Canc Drug Des 3 (1988) 205-216 and references therein
22. Valerio Jr. L.G., and Petersen D.R. Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects. Exp Mol Pathol 68 (2000) 1-12
23. Griffin R.J., Monzen H., Williams B.W., Park H., Lee S.H., and Song C.W. Arsenic trioxide induces selective tumor vascular damage via oxidative stress and increases thermosensitivity of tumors. Int J Hyperthermia 19 (2003) 575-589
24. Choi Y.J., Park J.W., Suh S.I., Mun K.C., Bae J.H., Song D.K., et al. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Int J Oncol 21 (2002) 603-610
25. Woo S.H., Park I.C., Park M.J., Lee H.C., Lee S.J., Chun Y.J., et al. Arsenic trioxide induces apoptosis through a reactive oxygen species - dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int J Oncol 21 (2002) 57-63
26. Tomilov A.P., and Chomutov N.E. Arsenic. In: Bard A.J. (Ed). Encyclopedia of electrochemistry of the elements Vol. 2 (1974), Marcel Dekker, New York 21-51 [chapter II-2]
27. Kovacic P., Ames J.R., Taylor E.C., and Ryan M.D. Electrochemistry of the anticancer agents methotrexate and α-difluoromethylornithine in iminium form. J Pharmaceut Sci 77 (1988) 99-1002
28. Crawford P.W., Lumme P., Elo H., Ryan M.D., and Kovacic P. Charge transfer-oxy radical mechanism for anticancer agents: mAMSA derivatives, rhodamine 123, and nickel salicylaldoximate. Free Rad Res Comm 3 (1987) 347-356
29. Vladimorov Y.A., Atanayev T.B., and Sherstnev M.P. Enhancement of chemiluminescence associated with lipid peroxidation by rhodamine dyes. Free Radic Biol Med 12 (1992) 43-52
30. Kovacic P., Ames J.R., Grogan J.V., Bazra B., and Ryan M.D. Anticancer quinones and quinolines: mode of action via electron transfer and oxidative stress. In: Dryhurst J., and Niki K. (Eds). Redox chemistry and interfacial behavior of biological molecules (1988), Plenum Press, New York 295-307
31. Kovacic P. Mechanism of central nervous system toxicity by irinotecan. Med Hypotheses 67 (2006) 997
32. Crawford P.W., Foye W.O., Ryan M.D., and Kovacic P. Cyclic voltammetry of quinolinium salts and related compounds; Correlation with structure and anticancer activity. J Pharmaceut Sci 76 (1987) 481-484
33. Baguley B.C., Wakelin L.P.G., Jacintho J., and Kovacic P. Mechanisms of action of DNA intercalating acridine- based drugs: How important are contributions from electron transfer and oxidative stress?. Curr Med Chem 10 (2003) 2643-2649
34. Ching L.-M., Zwain S., and Baguley B.C. Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice. Br J Cancer 90 (2004) 906-910 and references therein
35. Kovacic P. Fundamental electron transfer mechanism by pyrylum-type ions for the anticancer drugs 5,6-dimethylanthenone-4-acetic acid (FAA) and flavone-8-acetic acid. Curr Med Chem - Anti-Cancer Agents 5 (2005) 501-506
36. Kovacic P. Mechanism of drug and toxic actions of gossypol: focus on reactive oxygen species and electron transfer. Curr Med Chem 10 (2003) 2711-2718
37. Wardman P. Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia. Curr Med Chem 8 (2001) 739-761
38. Sato K., Akaike T., Suga M., Ando M., and Maeda H. Generation of free radicals from neocarzinostatin mediated by NADPH/cytochrome P-450 reductase via activation of enediyne chromophore. Biochem Biophys Res Commun 205 (1994) 1716-1723
39. Jones L.H., Harwig C.W., Wentworth Jr. P., Simeonov A., Wentworth A.D., and Py S. Conversion of enediynes into quinones by antibody catalysis and in aqueous buffers: implications for an alternative enediyne theraupeutic mechanism. J Am Chem Soc 123 (2001) 3607-3608
40. Gringauz A. Introduction to medicinal chemistry (1997), Wiley-VCH, New York p. 93-140, [chapter 4]
41. Kovacic P., and Pozos R.S. Cell signaling (mechanism and reproductive toxicity): redox chains, radicals, electrons, relays, conduit, electrochemistry, and other medical implications. Birth Defects Res (Part C) 78 (2006) 333-344